Education: Opioid Use Disorder (OUD)
OPIOID USE DISORDER: SCREENING, ASSESSMENT, AND REASSESSMENT; MEDICATION MANAGEMENT AND INTEGRATION INTO PRACTICE; AND SPECIAL POPULATIONS (On-Demand Webinar)
As the incidences of opioid use disorder continue despite decreases in prescription opioid supply, there is an increasing recognition that greater attention must be paid to improving access to effective treatment for OUD. To support the community in addressing OUD, the Arizona Psychiatric Society offers this on-demand webinar.
About this Webinar:
This three-module webinar on opioid use disorder (OUD) addresses crucial elements of screening, assessment, and reassessment for OUD; integrating medications for opiate use disorder (MOUD) into practice; and the vulnerabilities and considerations of providing culturally relevant care in the treatment of special populations for OUD.
This webinar is made available with support from the American Psychiatric Association Innovative Grant program.
This webinar is made available with support from the American Psychiatric Association Innovative Grant program.
OUR PROGRAM FACULTY AND LEARNING OBJECTIVES
Module 1 - Screening, Assessment, and Reassessment
Michelle O’Brien, MD, Psychiatrist, Specialty Behavioral Health Services, El Rio Health, 2020-2021 Addiction Medicine Fellow, University of Arizona College of Medicine, Tucson
Michelle O’Brien, MD, Psychiatrist, Specialty Behavioral Health Services, El Rio Health, 2020-2021 Addiction Medicine Fellow, University of Arizona College of Medicine, Tucson Dr. O’Brien received her medical degree from Western University of Health Sciences, Oregon in 2015 and did one year of Internal Medicine at The Wright Center in Scranton, Pennsylvania before transitioning to Psychiatry. She received her undergraduate degree from Grinnell College, Iowa, in 2011 with a B.A. in Biology. She has had an interest in medicine for quite some time but was initially drawn to Med/Psych and continues to thrive on a holistic approach to health care. Her interests in Psychiatry are varied including Addiction, Forensics, and inpatient or outpatient Adult. Michelle recently graduated from the University of Arizona Psychiatry Residency Program and in 2021 graduated from the University of Arizona College of Medicine, Tucson Addiction Medicine Fellowship Program. Dr. O’Brien is currently a Psychiatrist, Specialty Behavioral Health Services at El Rio Health in Tucson, Arizona.
Jamie Weinand, MD, Associate Medical Director - Grant Health Center, El Rio Health, 2020-2021 Addiction Medicine Fellow, University of Arizona College of Medicine, Tucson
Dr. Weinand obtained his medical degree from Boston University School of Medicine in 2017. He received his B.S. in Biology and a B.A. in Spanish from Duke University in 2012. Following his undergraduate graduation, Jamie completed a Fulbright scholarship in Mexico City in 2013. Professionally his interests include addiction medicine and LGBT healthcare. Jamie recently graduated from the Southern New Mexico Family Medicine Residency Program and in 2021 graduated from the University of Arizona College of Medicine, Tucson Addiction Medicine Fellowship Program. Dr. Weinand is currently the Associate Medical Director - Grant Health Center, at El Rio Health in Tucson, Arizona.
Learning Objectives - Module 1
1. Identify the risk factors for developing opioid use disorder (OUD) and aberrant behaviors in association with OUD. 2. Implement screening tools for OUD.3. Evaluate strategies for harm reduction, treatment options, and when to rescreen.
OUR PROGRAM FACULTY AND LEARNING OBJECTIVES
Module 2 - Medication Management and Integration into Practice
Elisa Gumm, DO, Medical Director of Addiction Services, Southern Arizona Veteran Affairs Health Care System, and Clinical Assistant Professor, Program Director, Addiction Medicine Fellowship, University of Arizona College of Medicine, Tucson
Dr. Gumm received her Doctor of Osteopathic from the West Virginia School of Osteopathic Medicine and completed her Psychiatry residency training at the University of Arizona. She is the Medical Director of Addiction Services at the Southern Arizona Veterans Affairs Health Care System in Tucson, AZ with over seven years of experience working in inpatient detoxification, outpatient addiction clinic, and inpatient residential rehabilitation programs. Over the last six years, Dr. Gumm has assisted other facilities in developing Medication-Assisted Treatment (MAT) clinics, increasing access to buprenorphine, and assisting in distributing over 5,000 Naloxone Kits. In 2018, Dr. Gumm developed the University of Arizona Addiction Medicine Fellowship in Tucson and is the Program Director. In 2020, she secured a $1.4M Health Resources and Services Administration (HRSA) grant to expand the fellowship and further enhance the infrastructure of the program.
Edwin Kim, MD, Addiction Psychiatrist, Medical Director, Charles O'Brien Center for Addiction Treatment at the University of Pennsylvania, Medical Director, Pennsylvania Physician Health Program, and Consultant, Arizona Physician Health Program
Dr. Kim is a Bay Area native. After graduating from the University of California, Los Angeles with a degree in Psychobiology, he earned his medical degree from Saint George’s University, School of Medicine. He completed residency in Psychiatry and served as Chief Resident of Clinical Education at Maricopa Medical Center in Phoenix, Arizona. He then completed fellowship in Addiction Psychiatry at the University of Pennsylvania. Dr. Kim has served on faculty at the Perelman School of Medicine at the University of Pennsylvania teaching medical students, residents, and fellows in the Department of Psychiatry. Additionally, he serves as medical director of the Charles O'Brien Center for Addiction Treatment at the University of Pennsylvania. Currently, he serves as a medical director of the Pennsylvania Physician Health Program and as a consultant to the Arizona Physician Health Program. Finally, he provides care for veterans coping with addiction and mental illness at the Palo Alto Veteran's Administration Medical Center.
Learning Objectives - Module 2
1. Identify and analyze the FDA-approved therapeutics for medications for opiate use disorder (MOUD) in an office-based opioid treatment or outpatient opioid treatment program. 2. Evaluate the practical considerations of integrating MOUD into a practice setting. 3. Identify methods of managing risk and implementing appropriate diversion programs for MOUD.
OUR PROGRAM FACULTY AND LEARNING OBJECTIVES
Module 3 - Special Populations
Jasleen Chhatwal, MBBS, MD, FAPAChief Medical Officer, Sierra Tucson, Past President, Arizona Psychiatric Society, Member, American Psychiatric Assn Council of Advocacy & Govt Relations, Assistant Professor of Psychiatry, College of Medicine - University of Arizona
Jasleen Chhatwal, MBBS, MD, serves as Chief Medical Officer at Sierra Tucson, a premier residential behavioral health treatment center. She is a board-certified psychiatrist, integrative medicine and addiction medicine physician with experience treating complex mental health disorders in inpatient, residential, and outpatient settings. She is intentional in treating the whole person, using psychotherapy, allopathic, neuro-therapeutic, integrative, evidence-based, and evidence-informed treatments. She believes each individual has a unique, authentic story and is grateful to all those who have entrusted her with their stories.
Learning Objectives - Module 3
1. Examine disparities in treatment for Opioid Use Disorder (OUD).2. Assess medical and psychiatric co-morbidities with OUD.3. Review OUD in women and during the peripatum period.4. Analyze impact of OUD in racial minority populations and justice-involved populations.